Awakening of SCHLAFEN 11 by immunohistochemistry: a new biomarker predicting response to chemotherapy
Open Access
- 10 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Virchows Archiv A Pathological Anatomy and Histopathology
- Vol. 478 (3), 567-568
- https://doi.org/10.1007/s00428-021-03051-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seqVirchows Archiv A Pathological Anatomy and Histopathology, 2020
- SLFN11 Blocks Stressed Replication Forks Independently of ATRMolecular Cell, 2018
- Awakening of “Schlafen11” to Tackle Chemotherapy Resistance in SCLCCancer Cell, 2017
- Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific MannerMolecular Cancer Research, 2016
- Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsClinical Cancer Research, 2016
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agentsProceedings of the National Academy of Sciences of the United States of America, 2012
- Molecular cloning of a human DNA repair geneNature, 1984